drugset
drugset / Trial / NCT01372982

Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Conditions

NCT01372982 ↗

Phase 1 Completed 36 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare bioavailability in healthy, post menopausal women subjects under fed conditions.

Timeline

Start
2008-04
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified 2.5 mg Oral

Indications

No indication recorded.